Skip to main content
. 2018 Oct 17;22(3):518–525. doi: 10.1007/s10120-018-0887-x

Table 4.

Comparison survivals between surgical specimens and biopsy specimens

Biopsy specimens Surgical specimens
mPFS
 Homo-HER2 10.8 (95% CI 6.9–19.4) 20.0 (95% CI 17.8–22.2)
 Hetero-HER2 6.1 (95% CI 5.3–8.2) 6.0 (95% CI 2.3–9.7)
mOS
 Homo-HER2 29.3 (95% CI 20.5–NR) NR
 Hetero-HER2 14.4 (95% CI 11.4–17.8) 14.0 (95% CI 11.9–16.1)

mPFS Median progression-free survival, mOS median overall survival, NR not reached, Homo-HER2 homogeneously HER2 positive, Hetero-HER2 heterogeneously HER2 positive